Rapid Dose Therapeutics Corp. Share Price
Equities
DOSE
CA75339A1012
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 CAD | 0.00% | +24.39% | +54.55% |
25/03 | Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding | CI |
08/02 | Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors | CI |
Sales 2022 | 1.75 2.39 146.1 | Sales 2023 | 0.72 0.98 59.9 | Capitalization | 9.32M 12.72M 777M |
---|---|---|---|---|---|
Net income 2022 | -8M -10.91M -667M | Net income 2023 | -3M -4.09M -250M | EV / Sales 2022 | 1,58,98,275 x |
Net Debt 2022 | 1.4M 1.91M 117M | Net Debt 2023 | 2.1M 2.86M 175M | EV / Sales 2023 | 1,58,94,851 x |
P/E ratio 2022 |
-3.01
x | P/E ratio 2023 |
-2.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.12% |
1 week | +24.39% | ||
Current month | +41.67% | ||
1 month | +41.67% | ||
3 months | +59.38% | ||
6 months | +13.33% | ||
Current year | +54.55% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Upsdell
CEO | Chief Executive Officer | - | 03/17/03 |
Doug Hyland
DFI | Director of Finance/CFO | - | 28/20/28 |
Corporate Officer/Principal | - | 23/19/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Sheldon
LAW | General Counsel | 77 | 06/19/06 |
John McKimm
BRD | Director/Board Member | - | 14/23/14 |
Director/Board Member | - | 13/20/13 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.255 | +2.00% | 81,000 |
25/24/25 | 0.25 | 0.00% | 107,970 |
24/24/24 | 0.25 | +13.64% | 36,000 |
23/24/23 | 0.22 | +4.76% | 222,585 |
22/24/22 | 0.21 | +2.44% | 5,000 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 08:08 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+54.55% | 22.5M | |
-10.84% | 187M |
- Stock Market
- Equities
- DOSE Stock